This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Tardive Dystonia and Ziprasidone: A Case Report

Prashant Tibrewal, MBBS; Amit Zutshi, MD; Suresh Bada Math, MD

Published: February 14, 2008

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Ziprasidone is an atypical antipsychotic with higheraffinity for human serotonin-2A (5-HT2A) receptors thandopamine-2 (D2) receptors. It is reported to have minimal extrapyramidalside effects similar to that of placebo.1 However,there are reports of acute dystonia with ziprasidone.2,3 AMEDLINE/PubMed search using keywords dystonia and ziprasidonerevealed no published reports of tardive dystonia withziprasidone.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 10

Quick Links: Movement Disorders


Sign-up to stay
up-to-date today!


Already registered? Sign In

Clinical and Practical Psychopharmacology

Skeletal and Dental Fractures Associated With Electroconvulsive Therapy

Recent data suggest the risk of skeletal or dental fracture with ECT may be as low as...